Mobile DNA elements, such as Insertion Sequence (IS) elements, transposons, integrative elements (e.g. integrative islands), ...

TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 registration-stage immune-oncology company ...

Skin microbes do more than coexist—they shape immune responses, repair tissue, and influence gene expression across your ...

Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect ...

Single-cell characterization of healthy fallopian tubes revealed shifts in cell and gene expression throughout the menstrual ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...

The field of synthetic biology is revolutionizing biomedicine, with applications in CAR-T cell therapy and biosensor-based ...

At All Doses Evaluated, VAX-24 Was Well-Tolerated and Demonstrated a Safety and Tolerability Profile Similar to Prevnar 20® (PCV20) -- -- At ...

Results provide proof-of-concept that ERK pathway reactivation might be an effective, biologically based therapy to prevent anthrax-induced lethality.

Therapeutic tolerogenic antigen-presenting cells can be generated in vivo by delivering, via lipid nanoparticles, mRNA coding for the inhibitory protein programmed death ligand 1, as shown in ...

Explore how machine learning is transforming immunology—from epitope prediction to smarter vaccine design—plus key challenges ...